Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery
- PMID: 36834573
- PMCID: PMC9963155
- DOI: 10.3390/ijms24043162
Rodent Models of Dilated Cardiomyopathy and Heart Failure for Translational Investigations and Therapeutic Discovery
Abstract
Even with modern therapy, patients with heart failure only have a 50% five-year survival rate. To improve the development of new therapeutic strategies, preclinical models of disease are needed to properly emulate the human condition. Determining the most appropriate model represents the first key step for reliable and translatable experimental research. Rodent models of heart failure provide a strategic compromise between human in vivo similarity and the ability to perform a larger number of experiments and explore many therapeutic candidates. We herein review the currently available rodent models of heart failure, summarizing their physiopathological basis, the timeline of the development of ventricular failure, and their specific clinical features. In order to facilitate the future planning of investigations in the field of heart failure, a detailed overview of the advantages and possible drawbacks of each model is provided.
Keywords: dilated cardiomyopathy; heart failure; review; rodent model.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
[Therapy of terminal dilated cardiomyopathy with growth hormone].Z Kardiol. 1998 Jun;87(6):425-35. doi: 10.1007/s003920050197. Z Kardiol. 1998. PMID: 9691412 Review. German.
-
Atrial natriuretic peptide affects cardiac remodeling, function, heart failure, and survival in a mouse model of dilated cardiomyopathy.Hypertension. 2014 Mar;63(3):514-9. doi: 10.1161/HYPERTENSIONAHA.113.02164. Epub 2013 Dec 30. Hypertension. 2014. PMID: 24379183 Free PMC article.
-
Differences of disease progression in congestive heart failure due to alcoholic as compared to idiopathic dilated cardiomyopathy.Eur Heart J. 1996 Feb;17(2):251-7. doi: 10.1093/oxfordjournals.eurheartj.a014842. Eur Heart J. 1996. PMID: 8732379
-
Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.Circ Heart Fail. 2013 Sep 1;6(5):913-21. doi: 10.1161/CIRCHEARTFAILURE.112.000120. Epub 2013 Jul 25. Circ Heart Fail. 2013. PMID: 23888044
-
A Comprehensive Review of Dilated Cardiomyopathy in Pre-clinical Animal Models in Addition to Herbal Treatment Options and Multi-modality Imaging Strategies.Cardiovasc Hematol Disord Drug Targets. 2023;22(4):207-225. doi: 10.2174/1871529X23666230123122808. Cardiovasc Hematol Disord Drug Targets. 2023. PMID: 36734898 Review.
Cited by
-
RhoA/ROCK Pathway Is Upregulated in Experimental Autoimmune Myocarditis and Is Inhibited by Simvastatin at the Stage of Myosin Light Chain Phosphorylation.Biomedicines. 2024 Mar 7;12(3):596. doi: 10.3390/biomedicines12030596. Biomedicines. 2024. PMID: 38540212 Free PMC article.
-
Is SIRT3 and Mitochondria a Reliable Target for Parkinson's Disease and Aging? A Narrative Review.Mol Neurobiol. 2024 Sep 17. doi: 10.1007/s12035-024-04486-w. Online ahead of print. Mol Neurobiol. 2024. PMID: 39287746 Review.
-
A Rat Model of Clinically Relevant Extracorporeal Circulation Develops Early Organ Dysfunctions.Int J Mol Sci. 2023 Apr 16;24(8):7338. doi: 10.3390/ijms24087338. Int J Mol Sci. 2023. PMID: 37108501 Free PMC article.
-
Realistic Aspects of Cardiac Ultrasound in Rats: Practical Tips for Improved Examination.J Imaging. 2024 Sep 6;10(9):219. doi: 10.3390/jimaging10090219. J Imaging. 2024. PMID: 39330439 Free PMC article. Review.
-
A Mouse Model of Dilated Cardiomyopathy Produced by Isoproterenol Acute Exposure Followed by 5-Fluorouracil Administration.J Cardiovasc Dev Dis. 2023 May 23;10(6):225. doi: 10.3390/jcdd10060225. J Cardiovasc Dev Dis. 2023. PMID: 37367390 Free PMC article.
References
-
- Heidenreich P.A., Albert N.M., Allen L.A., Bluemke D.A., Butler J., Fonarow G.C., Ikonomidis J.S., Khavjou O., Konstam M.A., Maddox T.M., et al. Forecasting the Impact of Heart Failure in the United States: A Policy Statement from the American Heart Association. Circ. Heart Fail. 2013;6:606–619. doi: 10.1161/HHF.0b013e318291329a. - DOI - PMC - PubMed
-
- Schilling C., Dalziel K., Nunn R., Du Plessis K., Shi W.Y., Celermajer D., Winlaw D., Weintraub R.G., Grigg L.E., Radford D.J., et al. The Fontan Epidemic: Population Projections from the Australia and New Zealand Fontan Registry. Int. J. Cardiol. 2016;219:14–19. doi: 10.1016/j.ijcard.2016.05.035. - DOI - PubMed
-
- Rossano J.W., Cherikh W.S., Chambers D.C., Goldfarb S., Hayes D.J., Khush K.K., Kucheryavaya A.Y., Toll A.E., Levvey B.J., Meiser B., et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Twenty-First Pediatric Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. J. Hear. Lung Transplant. Off. Publ. Int. Soc. Hear. Transplant. 2018;37:1184–1195. doi: 10.1016/j.healun.2018.07.018. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical